nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Ovarian Infertility Genes—PGR—multiple sclerosis	0.0137	0.0465	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR1—multiple sclerosis	0.0104	0.0352	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—VDR—multiple sclerosis	0.00956	0.0325	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—S1PR1—multiple sclerosis	0.00797	0.0271	CbGpPWpGaD
Goserelin—Pentagastrin—BCHE—multiple sclerosis	0.00731	1	CrCbGaD
Goserelin—GNRHR—Peptide GPCRs—CCR1—multiple sclerosis	0.00693	0.0236	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CXCR3—multiple sclerosis	0.00686	0.0233	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR2—multiple sclerosis	0.00667	0.0227	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PTGER4—multiple sclerosis	0.0047	0.016	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CXCR3—multiple sclerosis	0.00459	0.0156	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR2—multiple sclerosis	0.00447	0.0152	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00443	0.0151	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR5—multiple sclerosis	0.0043	0.0146	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00417	0.0142	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CXCR3—multiple sclerosis	0.00389	0.0132	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00381	0.013	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—GPR65—multiple sclerosis	0.00361	0.0123	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00357	0.0121	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CNR1—multiple sclerosis	0.00349	0.0119	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—S1PR1—multiple sclerosis	0.00337	0.0115	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00327	0.0111	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00327	0.0111	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.00323	0.011	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00297	0.0101	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR5—multiple sclerosis	0.00288	0.00979	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—GPR65—multiple sclerosis	0.00272	0.00925	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00262	0.00889	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00253	0.00859	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL13—multiple sclerosis	0.00249	0.00846	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR1—multiple sclerosis	0.00249	0.00846	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00246	0.00835	CbGpPWpGaD
Goserelin—GNRHR—GPCRs, Other—CCR5—multiple sclerosis	0.00244	0.0083	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00239	0.00813	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00233	0.00791	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00227	0.00771	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—S1PR1—multiple sclerosis	0.00226	0.00768	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00224	0.00762	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—POMC—multiple sclerosis	0.00222	0.00756	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00219	0.00744	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00219	0.00744	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00216	0.00736	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.0021	0.00716	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00194	0.00661	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00191	0.00648	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GPR65—multiple sclerosis	0.00182	0.00619	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL3—multiple sclerosis	0.00177	0.00603	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00175	0.00595	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—S1PR1—multiple sclerosis	0.00173	0.00589	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—PTGER4—multiple sclerosis	0.00171	0.0058	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR1—multiple sclerosis	0.00167	0.00566	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL13—multiple sclerosis	0.00167	0.00566	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCR3—multiple sclerosis	0.00165	0.0056	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RGS1—multiple sclerosis	0.00162	0.00551	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR2—multiple sclerosis	0.0016	0.00545	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00158	0.00538	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00156	0.0053	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GPR65—multiple sclerosis	0.00154	0.00523	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00151	0.00512	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.0015	0.0051	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CNR1—multiple sclerosis	0.00148	0.00503	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RGS1—multiple sclerosis	0.00147	0.00501	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00145	0.00493	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00141	0.00479	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00141	0.00478	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR1—multiple sclerosis	0.00141	0.00478	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GPR65—multiple sclerosis	0.0014	0.00475	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00136	0.00461	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LINGO1—multiple sclerosis	0.00135	0.00459	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL10—multiple sclerosis	0.00133	0.00453	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.0013	0.00442	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR1—multiple sclerosis	0.00128	0.00434	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL13—multiple sclerosis	0.00128	0.00434	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00128	0.00434	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL3—multiple sclerosis	0.00119	0.00403	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00117	0.00398	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TAGAP—multiple sclerosis	0.00117	0.00398	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—S1PR1—multiple sclerosis	0.00116	0.00394	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL5—multiple sclerosis	0.00115	0.0039	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—PTGER4—multiple sclerosis	0.00114	0.00388	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCR3—multiple sclerosis	0.0011	0.00375	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—RGS1—multiple sclerosis	0.00109	0.00369	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR2—multiple sclerosis	0.00107	0.00365	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00106	0.0036	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00104	0.00353	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR5—multiple sclerosis	0.00103	0.00351	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GPR65—multiple sclerosis	0.00103	0.0035	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—S1PR1—multiple sclerosis	0.00102	0.00348	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00101	0.00343	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GPC5—multiple sclerosis	0.000995	0.00338	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CNR1—multiple sclerosis	0.00099	0.00337	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RGS1—multiple sclerosis	0.000986	0.00335	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000964	0.00328	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000941	0.0032	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR1—multiple sclerosis	0.000941	0.0032	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GPR65—multiple sclerosis	0.000934	0.00318	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000931	0.00317	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL3—multiple sclerosis	0.00091	0.00309	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000908	0.00309	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000906	0.00308	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LINGO1—multiple sclerosis	0.000904	0.00307	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL10—multiple sclerosis	0.000892	0.00303	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000876	0.00298	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RGS1—multiple sclerosis	0.00087	0.00296	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR1—multiple sclerosis	0.000855	0.00291	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL13—multiple sclerosis	0.000855	0.00291	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000852	0.0029	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000846	0.00288	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CNR1—multiple sclerosis	0.000836	0.00284	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GPR65—multiple sclerosis	0.000825	0.0028	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR2—multiple sclerosis	0.000823	0.0028	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—POMC—multiple sclerosis	0.000807	0.00275	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—multiple sclerosis	0.00079	0.00269	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TAGAP—multiple sclerosis	0.000783	0.00266	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL5—multiple sclerosis	0.000768	0.00261	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR1—multiple sclerosis	0.000759	0.00258	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR1—multiple sclerosis	0.000754	0.00256	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL13—multiple sclerosis	0.000754	0.00256	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000753	0.00256	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00071	0.00241	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000694	0.00236	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—multiple sclerosis	0.000691	0.00235	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—S1PR1—multiple sclerosis	0.000685	0.00233	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000684	0.00232	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GPC5—multiple sclerosis	0.000666	0.00227	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000648	0.0022	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000645	0.00219	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000623	0.00212	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL3—multiple sclerosis	0.000609	0.00207	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR2—multiple sclerosis	0.000606	0.00206	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL5—multiple sclerosis	0.000588	0.002	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PTGER4—multiple sclerosis	0.000586	0.00199	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000584	0.00198	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RGS1—multiple sclerosis	0.000582	0.00198	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000575	0.00196	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCR3—multiple sclerosis	0.000566	0.00192	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR1—multiple sclerosis	0.00056	0.0019	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GPR65—multiple sclerosis	0.000552	0.00188	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR2—multiple sclerosis	0.000551	0.00187	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000542	0.00184	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—POMC—multiple sclerosis	0.00054	0.00184	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL3—multiple sclerosis	0.000537	0.00183	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR5—multiple sclerosis	0.00053	0.0018	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL2—multiple sclerosis	0.000529	0.0018	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2RA—multiple sclerosis	0.000522	0.00178	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTGER4—multiple sclerosis	0.000517	0.00176	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PGR—multiple sclerosis	0.000509	0.00173	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR1—multiple sclerosis	0.000508	0.00173	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL13—multiple sclerosis	0.000505	0.00172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR1—multiple sclerosis	0.000505	0.00172	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000504	0.00171	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCR3—multiple sclerosis	0.0005	0.0017	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD28—multiple sclerosis	0.000495	0.00168	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR2—multiple sclerosis	0.000486	0.00165	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL10—multiple sclerosis	0.000458	0.00156	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—POMC—multiple sclerosis	0.000456	0.00155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR1—multiple sclerosis	0.000448	0.00152	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—multiple sclerosis	0.000434	0.00147	CbGpPWpGaD
Goserelin—Sweating—Methotrexate—multiple sclerosis	0.000418	0.000599	CcSEcCtD
Goserelin—Infection—Methylprednisolone—multiple sclerosis	0.000418	0.000598	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000416	0.00142	CbGpPWpGaD
Goserelin—Haematuria—Methotrexate—multiple sclerosis	0.000416	0.000595	CcSEcCtD
Goserelin—Shock—Triamcinolone—multiple sclerosis	0.000414	0.000593	CcSEcCtD
Goserelin—Insomnia—Prednisolone—multiple sclerosis	0.000414	0.000593	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—POMC—multiple sclerosis	0.000414	0.00141	CbGpPWpGaD
Goserelin—Alopecia—Prednisone—multiple sclerosis	0.000414	0.000593	CcSEcCtD
Goserelin—Shock—Methylprednisolone—multiple sclerosis	0.000414	0.000592	CcSEcCtD
Goserelin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000412	0.00059	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—multiple sclerosis	0.000411	0.000589	CcSEcCtD
Goserelin—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000411	0.000589	CcSEcCtD
Goserelin—Paraesthesia—Prednisolone—multiple sclerosis	0.000411	0.000589	CcSEcCtD
Goserelin—Tachycardia—Triamcinolone—multiple sclerosis	0.000411	0.000589	CcSEcCtD
Goserelin—Mental disorder—Prednisone—multiple sclerosis	0.000411	0.000588	CcSEcCtD
Goserelin—Nausea—Azathioprine—multiple sclerosis	0.00041	0.000587	CcSEcCtD
Goserelin—Tachycardia—Methylprednisolone—multiple sclerosis	0.00041	0.000587	CcSEcCtD
Goserelin—Skin disorder—Methylprednisolone—multiple sclerosis	0.000408	0.000584	CcSEcCtD
Goserelin—Malnutrition—Prednisone—multiple sclerosis	0.000408	0.000584	CcSEcCtD
Goserelin—Erythema—Prednisone—multiple sclerosis	0.000408	0.000584	CcSEcCtD
Goserelin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000407	0.000583	CcSEcCtD
Goserelin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000406	0.000582	CcSEcCtD
Goserelin—Convulsion—Dexamethasone—multiple sclerosis	0.000406	0.000581	CcSEcCtD
Goserelin—Convulsion—Betamethasone—multiple sclerosis	0.000406	0.000581	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCL2—multiple sclerosis	0.000405	0.00138	CbGpPWpGaD
Goserelin—Hypertension—Dexamethasone—multiple sclerosis	0.000404	0.000579	CcSEcCtD
Goserelin—Hypertension—Betamethasone—multiple sclerosis	0.000404	0.000579	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CXCL10—multiple sclerosis	0.000404	0.00137	CbGpPWpGaD
Goserelin—Asthenia—Mitoxantrone—multiple sclerosis	0.000401	0.000573	CcSEcCtD
Goserelin—Myalgia—Betamethasone—multiple sclerosis	0.000399	0.000571	CcSEcCtD
Goserelin—Myalgia—Dexamethasone—multiple sclerosis	0.000399	0.000571	CcSEcCtD
Goserelin—Anxiety—Dexamethasone—multiple sclerosis	0.000397	0.000569	CcSEcCtD
Goserelin—Anxiety—Betamethasone—multiple sclerosis	0.000397	0.000569	CcSEcCtD
Goserelin—Discomfort—Betamethasone—multiple sclerosis	0.000394	0.000564	CcSEcCtD
Goserelin—Discomfort—Dexamethasone—multiple sclerosis	0.000394	0.000564	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCL5—multiple sclerosis	0.000394	0.00134	CbGpPWpGaD
Goserelin—Haemoglobin—Methotrexate—multiple sclerosis	0.000394	0.000563	CcSEcCtD
Goserelin—Hypotension—Methylprednisolone—multiple sclerosis	0.000393	0.000562	CcSEcCtD
Goserelin—Pain—Prednisolone—multiple sclerosis	0.000392	0.000561	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—multiple sclerosis	0.000392	0.000561	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—multiple sclerosis	0.000392	0.000561	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—multiple sclerosis	0.000391	0.00133	CbGpPWpGaD
Goserelin—Pharyngitis—Methotrexate—multiple sclerosis	0.000389	0.000556	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000387	0.000554	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000385	0.00131	CbGpPWpGaD
Goserelin—Vision blurred—Prednisone—multiple sclerosis	0.000384	0.00055	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—multiple sclerosis	0.000384	0.000549	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000384	0.000549	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000383	0.000548	CcSEcCtD
Goserelin—Oedema—Dexamethasone—multiple sclerosis	0.000382	0.000547	CcSEcCtD
Goserelin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000382	0.000547	CcSEcCtD
Goserelin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000382	0.000547	CcSEcCtD
Goserelin—Oedema—Betamethasone—multiple sclerosis	0.000382	0.000547	CcSEcCtD
Goserelin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000382	0.000547	CcSEcCtD
Goserelin—Insomnia—Triamcinolone—multiple sclerosis	0.000381	0.000545	CcSEcCtD
Goserelin—Insomnia—Methylprednisolone—multiple sclerosis	0.00038	0.000544	CcSEcCtD
Goserelin—Infection—Betamethasone—multiple sclerosis	0.00038	0.000544	CcSEcCtD
Goserelin—Infection—Dexamethasone—multiple sclerosis	0.00038	0.000544	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000378	0.000542	CcSEcCtD
Goserelin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000378	0.000542	CcSEcCtD
Goserelin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000378	0.00054	CcSEcCtD
Goserelin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000377	0.00054	CcSEcCtD
Goserelin—Anaemia—Prednisone—multiple sclerosis	0.000377	0.00054	CcSEcCtD
Goserelin—Shock—Dexamethasone—multiple sclerosis	0.000376	0.000538	CcSEcCtD
Goserelin—Shock—Betamethasone—multiple sclerosis	0.000376	0.000538	CcSEcCtD
Goserelin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000376	0.000538	CcSEcCtD
Goserelin—Nervous system disorder—Betamethasone—multiple sclerosis	0.000375	0.000537	CcSEcCtD
Goserelin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000375	0.000537	CcSEcCtD
Goserelin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000374	0.000536	CcSEcCtD
Goserelin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000374	0.000536	CcSEcCtD
Goserelin—Tachycardia—Dexamethasone—multiple sclerosis	0.000373	0.000534	CcSEcCtD
Goserelin—Tachycardia—Betamethasone—multiple sclerosis	0.000373	0.000534	CcSEcCtD
Goserelin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000371	0.000531	CcSEcCtD
Goserelin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00037	0.00053	CcSEcCtD
Goserelin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00037	0.000529	CcSEcCtD
Goserelin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00037	0.000529	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—TYK2—multiple sclerosis	0.000368	0.00125	CbGpPWpGaD
Goserelin—Malaise—Prednisone—multiple sclerosis	0.000368	0.000527	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—multiple sclerosis	0.000366	0.000524	CcSEcCtD
Goserelin—Anorexia—Betamethasone—multiple sclerosis	0.000364	0.000522	CcSEcCtD
Goserelin—Anorexia—Dexamethasone—multiple sclerosis	0.000364	0.000522	CcSEcCtD
Goserelin—Urticaria—Prednisolone—multiple sclerosis	0.000364	0.000521	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—multiple sclerosis	0.000363	0.00052	CcSEcCtD
Goserelin—Fatigue—Triamcinolone—multiple sclerosis	0.000363	0.00052	CcSEcCtD
Goserelin—Fatigue—Methylprednisolone—multiple sclerosis	0.000362	0.000519	CcSEcCtD
Goserelin—Pain—Triamcinolone—multiple sclerosis	0.00036	0.000516	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCL3—multiple sclerosis	0.00036	0.00122	CbGpPWpGaD
Goserelin—Hypotension—Betamethasone—multiple sclerosis	0.000357	0.000511	CcSEcCtD
Goserelin—Hypotension—Dexamethasone—multiple sclerosis	0.000357	0.000511	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—multiple sclerosis	0.000355	0.000509	CcSEcCtD
Goserelin—Vomiting—Mitoxantrone—multiple sclerosis	0.000355	0.000508	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCR5—multiple sclerosis	0.000355	0.00121	CbGpPWpGaD
Goserelin—Immune system disorder—Methotrexate—multiple sclerosis	0.000354	0.000506	CcSEcCtD
Goserelin—Convulsion—Prednisone—multiple sclerosis	0.000353	0.000506	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CD86—multiple sclerosis	0.000353	0.0012	CbGpPWpGaD
Goserelin—Hypertension—Prednisone—multiple sclerosis	0.000352	0.000504	CcSEcCtD
Goserelin—Rash—Mitoxantrone—multiple sclerosis	0.000352	0.000504	CcSEcCtD
Goserelin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000352	0.000504	CcSEcCtD
Goserelin—Chills—Methotrexate—multiple sclerosis	0.000351	0.000503	CcSEcCtD
Goserelin—Headache—Mitoxantrone—multiple sclerosis	0.00035	0.000501	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL2RA—multiple sclerosis	0.00035	0.00119	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000348	0.000499	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000348	0.000499	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCL5—multiple sclerosis	0.000348	0.00118	CbGpPWpGaD
Goserelin—Arthralgia—Prednisone—multiple sclerosis	0.000347	0.000497	CcSEcCtD
Goserelin—Myalgia—Prednisone—multiple sclerosis	0.000347	0.000497	CcSEcCtD
Goserelin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000347	0.000497	CcSEcCtD
Goserelin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000346	0.000496	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PTGER4—multiple sclerosis	0.000346	0.00118	CbGpPWpGaD
Goserelin—Anxiety—Prednisone—multiple sclerosis	0.000346	0.000495	CcSEcCtD
Goserelin—Alopecia—Methotrexate—multiple sclerosis	0.000346	0.000495	CcSEcCtD
Goserelin—Insomnia—Betamethasone—multiple sclerosis	0.000346	0.000495	CcSEcCtD
Goserelin—Insomnia—Dexamethasone—multiple sclerosis	0.000346	0.000495	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000345	0.000494	CcSEcCtD
Goserelin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000344	0.000492	CcSEcCtD
Goserelin—Paraesthesia—Betamethasone—multiple sclerosis	0.000343	0.000491	CcSEcCtD
Goserelin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000343	0.000491	CcSEcCtD
Goserelin—Discomfort—Prednisone—multiple sclerosis	0.000343	0.000491	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—multiple sclerosis	0.000343	0.000491	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—PGR—multiple sclerosis	0.000341	0.00116	CbGpPWpGaD
Goserelin—Erythema—Methotrexate—multiple sclerosis	0.000341	0.000488	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—multiple sclerosis	0.000341	0.000488	CcSEcCtD
Goserelin—Hypersensitivity—Prednisolone—multiple sclerosis	0.000338	0.000483	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—IL2—multiple sclerosis	0.000337	0.00115	CbGpPWpGaD
Goserelin—Dyspepsia—Betamethasone—multiple sclerosis	0.000336	0.000482	CcSEcCtD
Goserelin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000336	0.000482	CcSEcCtD
Goserelin—Urticaria—Triamcinolone—multiple sclerosis	0.000335	0.000479	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCR3—multiple sclerosis	0.000334	0.00114	CbGpPWpGaD
Goserelin—Urticaria—Methylprednisolone—multiple sclerosis	0.000334	0.000478	CcSEcCtD
Goserelin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000333	0.000477	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000333	0.000477	CcSEcCtD
Goserelin—Oedema—Prednisone—multiple sclerosis	0.000333	0.000477	CcSEcCtD
Goserelin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000332	0.000476	CcSEcCtD
Goserelin—Decreased appetite—Betamethasone—multiple sclerosis	0.000332	0.000476	CcSEcCtD
Goserelin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000332	0.000476	CcSEcCtD
Goserelin—Nausea—Mitoxantrone—multiple sclerosis	0.000332	0.000475	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CD28—multiple sclerosis	0.000331	0.00113	CbGpPWpGaD
Goserelin—Infection—Prednisone—multiple sclerosis	0.000331	0.000473	CcSEcCtD
Goserelin—Back pain—Methotrexate—multiple sclerosis	0.00033	0.000472	CcSEcCtD
Goserelin—Fatigue—Betamethasone—multiple sclerosis	0.00033	0.000472	CcSEcCtD
Goserelin—Fatigue—Dexamethasone—multiple sclerosis	0.00033	0.000472	CcSEcCtD
Goserelin—Shock—Prednisone—multiple sclerosis	0.000328	0.000469	CcSEcCtD
Goserelin—Pain—Betamethasone—multiple sclerosis	0.000327	0.000468	CcSEcCtD
Goserelin—Pain—Dexamethasone—multiple sclerosis	0.000327	0.000468	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—multiple sclerosis	0.000326	0.000467	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR2—multiple sclerosis	0.000325	0.00111	CbGpPWpGaD
Goserelin—Tachycardia—Prednisone—multiple sclerosis	0.000325	0.000465	CcSEcCtD
Goserelin—Skin disorder—Prednisone—multiple sclerosis	0.000323	0.000463	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SPP1—multiple sclerosis	0.000322	0.00109	CbGpPWpGaD
Goserelin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000322	0.000461	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—multiple sclerosis	0.000321	0.00046	CcSEcCtD
Goserelin—Anorexia—Prednisone—multiple sclerosis	0.000317	0.000454	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000316	0.000453	CcSEcCtD
Goserelin—Anaemia—Methotrexate—multiple sclerosis	0.000315	0.000451	CcSEcCtD
Goserelin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000315	0.000451	CcSEcCtD
Goserelin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000315	0.000451	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCR5—multiple sclerosis	0.000313	0.00106	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000313	0.000447	CcSEcCtD
Goserelin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000313	0.000447	CcSEcCtD
Goserelin—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00031	0.000444	CcSEcCtD
Goserelin—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00031	0.000443	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL2RA—multiple sclerosis	0.000309	0.00105	CbGpPWpGaD
Goserelin—Malaise—Methotrexate—multiple sclerosis	0.000307	0.00044	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL2—multiple sclerosis	0.000306	0.00104	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—POMC—multiple sclerosis	0.000305	0.00104	CbGpPWpGaD
Goserelin—Leukopenia—Methotrexate—multiple sclerosis	0.000305	0.000437	CcSEcCtD
Goserelin—Urticaria—Betamethasone—multiple sclerosis	0.000304	0.000435	CcSEcCtD
Goserelin—Urticaria—Dexamethasone—multiple sclerosis	0.000304	0.000435	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000303	0.000434	CcSEcCtD
Goserelin—Dizziness—Prednisolone—multiple sclerosis	0.000303	0.000434	CcSEcCtD
Goserelin—Asthenia—Triamcinolone—multiple sclerosis	0.000302	0.000433	CcSEcCtD
Goserelin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000302	0.000433	CcSEcCtD
Goserelin—Abdominal pain—Betamethasone—multiple sclerosis	0.000302	0.000433	CcSEcCtD
Goserelin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000302	0.000433	CcSEcCtD
Goserelin—Body temperature increased—Betamethasone—multiple sclerosis	0.000302	0.000433	CcSEcCtD
Goserelin—Asthenia—Methylprednisolone—multiple sclerosis	0.000302	0.000432	CcSEcCtD
Goserelin—Insomnia—Prednisone—multiple sclerosis	0.000301	0.000431	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CNR1—multiple sclerosis	0.0003	0.00102	CbGpPWpGaD
Goserelin—Paraesthesia—Prednisone—multiple sclerosis	0.000299	0.000428	CcSEcCtD
Goserelin—Pruritus—Triamcinolone—multiple sclerosis	0.000298	0.000427	CcSEcCtD
Goserelin—Cough—Methotrexate—multiple sclerosis	0.000297	0.000426	CcSEcCtD
Goserelin—Pruritus—Methylprednisolone—multiple sclerosis	0.000297	0.000426	CcSEcCtD
Goserelin—Convulsion—Methotrexate—multiple sclerosis	0.000295	0.000423	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—multiple sclerosis	0.000293	0.000419	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—multiple sclerosis	0.00029	0.000415	CcSEcCtD
Goserelin—Chest pain—Methotrexate—multiple sclerosis	0.00029	0.000415	CcSEcCtD
Goserelin—Myalgia—Methotrexate—multiple sclerosis	0.00029	0.000415	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—multiple sclerosis	0.000289	0.000414	CcSEcCtD
Goserelin—Rash—Prednisolone—multiple sclerosis	0.000289	0.000413	CcSEcCtD
Goserelin—Dermatitis—Prednisolone—multiple sclerosis	0.000289	0.000413	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000288	0.000413	CcSEcCtD
Goserelin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000288	0.000412	CcSEcCtD
Goserelin—Fatigue—Prednisone—multiple sclerosis	0.000287	0.000411	CcSEcCtD
Goserelin—Headache—Prednisolone—multiple sclerosis	0.000287	0.000411	CcSEcCtD
Goserelin—Discomfort—Methotrexate—multiple sclerosis	0.000287	0.00041	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—APOE—multiple sclerosis	0.000285	0.000969	CbGpPWpGaD
Goserelin—Constipation—Prednisone—multiple sclerosis	0.000285	0.000407	CcSEcCtD
Goserelin—Confusional state—Methotrexate—multiple sclerosis	0.000281	0.000402	CcSEcCtD
Goserelin—Dizziness—Triamcinolone—multiple sclerosis	0.000279	0.000399	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000278	0.000398	CcSEcCtD
Goserelin—Dizziness—Methylprednisolone—multiple sclerosis	0.000278	0.000398	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—POMC—multiple sclerosis	0.000277	0.000943	CbGpPWpGaD
Goserelin—Infection—Methotrexate—multiple sclerosis	0.000276	0.000396	CcSEcCtD
Goserelin—Feeling abnormal—Prednisone—multiple sclerosis	0.000274	0.000393	CcSEcCtD
Goserelin—Asthenia—Betamethasone—multiple sclerosis	0.000274	0.000393	CcSEcCtD
Goserelin—Asthenia—Dexamethasone—multiple sclerosis	0.000274	0.000393	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—multiple sclerosis	0.000273	0.000391	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000272	0.00039	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000272	0.00039	CcSEcCtD
Goserelin—Nausea—Prednisolone—multiple sclerosis	0.000272	0.00039	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCL2—multiple sclerosis	0.000271	0.000923	CbGpPWpGaD
Goserelin—Pruritus—Betamethasone—multiple sclerosis	0.00027	0.000387	CcSEcCtD
Goserelin—Pruritus—Dexamethasone—multiple sclerosis	0.00027	0.000387	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CXCL10—multiple sclerosis	0.00027	0.000919	CbGpPWpGaD
Goserelin—Skin disorder—Methotrexate—multiple sclerosis	0.00027	0.000387	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000269	0.000385	CcSEcCtD
Goserelin—Vomiting—Triamcinolone—multiple sclerosis	0.000268	0.000383	CcSEcCtD
Goserelin—Vomiting—Methylprednisolone—multiple sclerosis	0.000267	0.000383	CcSEcCtD
Goserelin—Rash—Triamcinolone—multiple sclerosis	0.000266	0.00038	CcSEcCtD
Goserelin—Dermatitis—Triamcinolone—multiple sclerosis	0.000265	0.00038	CcSEcCtD
Goserelin—Anorexia—Methotrexate—multiple sclerosis	0.000265	0.00038	CcSEcCtD
Goserelin—Rash—Methylprednisolone—multiple sclerosis	0.000265	0.000379	CcSEcCtD
Goserelin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000265	0.000379	CcSEcCtD
Goserelin—Urticaria—Prednisone—multiple sclerosis	0.000264	0.000379	CcSEcCtD
Goserelin—Headache—Triamcinolone—multiple sclerosis	0.000264	0.000378	CcSEcCtD
Goserelin—Headache—Methylprednisolone—multiple sclerosis	0.000263	0.000377	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—multiple sclerosis	0.000263	0.000377	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—multiple sclerosis	0.000263	0.000377	CcSEcCtD
Goserelin—Diarrhoea—Betamethasone—multiple sclerosis	0.000262	0.000374	CcSEcCtD
Goserelin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000262	0.000374	CcSEcCtD
Goserelin—Hypotension—Methotrexate—multiple sclerosis	0.00026	0.000372	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CD80—multiple sclerosis	0.000258	0.000876	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000253	0.000363	CcSEcCtD
Goserelin—Dizziness—Betamethasone—multiple sclerosis	0.000253	0.000362	CcSEcCtD
Goserelin—Dizziness—Dexamethasone—multiple sclerosis	0.000253	0.000362	CcSEcCtD
Goserelin—Insomnia—Methotrexate—multiple sclerosis	0.000252	0.00036	CcSEcCtD
Goserelin—Nausea—Triamcinolone—multiple sclerosis	0.00025	0.000358	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—multiple sclerosis	0.00025	0.000358	CcSEcCtD
Goserelin—Nausea—Methylprednisolone—multiple sclerosis	0.00025	0.000357	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—multiple sclerosis	0.000248	0.000355	CcSEcCtD
Goserelin—Somnolence—Methotrexate—multiple sclerosis	0.000247	0.000354	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—TYK2—multiple sclerosis	0.000246	0.000838	CbGpPWpGaD
Goserelin—Hypersensitivity—Prednisone—multiple sclerosis	0.000245	0.000351	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—multiple sclerosis	0.000245	0.000351	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—POMC—multiple sclerosis	0.000245	0.000832	CbGpPWpGaD
Goserelin—Vomiting—Dexamethasone—multiple sclerosis	0.000243	0.000348	CcSEcCtD
Goserelin—Vomiting—Betamethasone—multiple sclerosis	0.000243	0.000348	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—multiple sclerosis	0.000242	0.000346	CcSEcCtD
Goserelin—Rash—Betamethasone—multiple sclerosis	0.000241	0.000345	CcSEcCtD
Goserelin—Rash—Dexamethasone—multiple sclerosis	0.000241	0.000345	CcSEcCtD
Goserelin—Dermatitis—Dexamethasone—multiple sclerosis	0.000241	0.000345	CcSEcCtD
Goserelin—Dermatitis—Betamethasone—multiple sclerosis	0.000241	0.000345	CcSEcCtD
Goserelin—Fatigue—Methotrexate—multiple sclerosis	0.00024	0.000343	CcSEcCtD
Goserelin—Headache—Betamethasone—multiple sclerosis	0.000239	0.000343	CcSEcCtD
Goserelin—Headache—Dexamethasone—multiple sclerosis	0.000239	0.000343	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCL2—multiple sclerosis	0.000239	0.000814	CbGpPWpGaD
Goserelin—Asthenia—Prednisone—multiple sclerosis	0.000239	0.000342	CcSEcCtD
Goserelin—Pain—Methotrexate—multiple sclerosis	0.000238	0.000341	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CD86—multiple sclerosis	0.000236	0.000804	CbGpPWpGaD
Goserelin—Pruritus—Prednisone—multiple sclerosis	0.000236	0.000337	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000234	0.000797	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL5—multiple sclerosis	0.000233	0.000791	CbGpPWpGaD
Goserelin—Feeling abnormal—Methotrexate—multiple sclerosis	0.000229	0.000328	CcSEcCtD
Goserelin—Diarrhoea—Prednisone—multiple sclerosis	0.000228	0.000326	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000228	0.000326	CcSEcCtD
Goserelin—Nausea—Dexamethasone—multiple sclerosis	0.000227	0.000325	CcSEcCtD
Goserelin—Nausea—Betamethasone—multiple sclerosis	0.000227	0.000325	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—IL2—multiple sclerosis	0.000226	0.000768	CbGpPWpGaD
Goserelin—Urticaria—Methotrexate—multiple sclerosis	0.000221	0.000316	CcSEcCtD
Goserelin—Dizziness—Prednisone—multiple sclerosis	0.00022	0.000315	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—multiple sclerosis	0.00022	0.000315	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—multiple sclerosis	0.00022	0.000315	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—TYK2—multiple sclerosis	0.000217	0.000739	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SPP1—multiple sclerosis	0.000215	0.000733	CbGpPWpGaD
Goserelin—Vomiting—Prednisone—multiple sclerosis	0.000212	0.000303	CcSEcCtD
Goserelin—Rash—Prednisone—multiple sclerosis	0.00021	0.0003	CcSEcCtD
Goserelin—Dermatitis—Prednisone—multiple sclerosis	0.00021	0.0003	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR5—multiple sclerosis	0.00021	0.000713	CbGpPWpGaD
Goserelin—Headache—Prednisone—multiple sclerosis	0.000209	0.000299	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IL2RA—multiple sclerosis	0.000207	0.000702	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—multiple sclerosis	0.000205	0.000697	CbGpPWpGaD
Goserelin—Hypersensitivity—Methotrexate—multiple sclerosis	0.000205	0.000293	CcSEcCtD
Goserelin—Asthenia—Methotrexate—multiple sclerosis	0.0002	0.000286	CcSEcCtD
Goserelin—Nausea—Prednisone—multiple sclerosis	0.000198	0.000283	CcSEcCtD
Goserelin—Pruritus—Methotrexate—multiple sclerosis	0.000197	0.000282	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—APOE—multiple sclerosis	0.000191	0.000648	CbGpPWpGaD
Goserelin—Diarrhoea—Methotrexate—multiple sclerosis	0.00019	0.000272	CcSEcCtD
Goserelin—Dizziness—Methotrexate—multiple sclerosis	0.000184	0.000263	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL2—multiple sclerosis	0.000181	0.000615	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—multiple sclerosis	0.00018	0.000612	CbGpPWpGaD
Goserelin—Vomiting—Methotrexate—multiple sclerosis	0.000177	0.000253	CcSEcCtD
Goserelin—Rash—Methotrexate—multiple sclerosis	0.000175	0.000251	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—multiple sclerosis	0.000175	0.000251	CcSEcCtD
Goserelin—Headache—Methotrexate—multiple sclerosis	0.000174	0.000249	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CD80—multiple sclerosis	0.000172	0.000586	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—multiple sclerosis	0.000171	0.000582	CbGpPWpGaD
Goserelin—Nausea—Methotrexate—multiple sclerosis	0.000165	0.000237	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—POMC—multiple sclerosis	0.000164	0.000557	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—multiple sclerosis	0.00016	0.000545	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MAPK1—multiple sclerosis	0.000157	0.000533	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—multiple sclerosis	0.000152	0.000518	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TYK2—multiple sclerosis	0.000146	0.000495	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MYC—multiple sclerosis	0.000141	0.000481	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—multiple sclerosis	0.000141	0.00048	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MAPK1—multiple sclerosis	0.000138	0.000471	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—multiple sclerosis	0.000121	0.000412	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—multiple sclerosis	0.000121	0.00041	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—multiple sclerosis	0.000115	0.00039	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—multiple sclerosis	0.000106	0.000362	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—multiple sclerosis	0.000102	0.000347	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MYC—multiple sclerosis	9.47e-05	0.000322	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—multiple sclerosis	9.45e-05	0.000321	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MAPK1—multiple sclerosis	9.27e-05	0.000315	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—multiple sclerosis	7.12e-05	0.000242	CbGpPWpGaD
